Sticking to it: The effect of maximally assisted therapy on antiretroviral treatment adherence among individuals living with HIV who are unstably housed

AIDS and Behavior

Volumn 15, Issue 8, 2011, Pages 1612-1622

  Parashar, Surita ^a,b   Palmer, A K ^a,b   O'Brien, Nadia ^a,b   Chan, Keith ^a   Shen, Anya ^a   Coulter, Suzy ^c   Montaner, Julio S G ^a,d   Hogg, Robert S ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c VANCOUVER COASTAL HEALTH   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adherence; Antiretroviral therapy; Community health services; HIV; Housing

Indexed keywords

ADULT; ARTICLE; CANADA; COMMUNITY CARE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE DELIVERY; HIGH RISK BEHAVIOR; HOMELESSNESS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; SOCIAL SUPPORT; SOCIOECONOMICS; STATISTICAL MODEL; UTILIZATION REVIEW;

ADULT; BRITISH COLUMBIA; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOMELESS PERSONS; HOUSING; HUMANS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RISK-TAKING; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS;

EID: 84555203842     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-011-0026-8     Document Type: Article

References (74)

1. Aidala AA, Lee G, Abramson DM, Messeri P, Siegler A. Housing need, housing assistance, and connection to HIV medical care. AIDS Behav. 2007;11(6):101-15.
2. Buchanan D, Kee R, Sadowski LS, Garcia D. The health impact of supportive housing for HIV-positive homeless patients: A randomized controlled trial. Am J Public Health. 2009;99(Suppl 3):S675-80.
3. Stewart K, Cianfrini L, Walker J. Stress, social support and housing are related to health status among HIV-positive persons in the Deep South of the United States. AIDS Care. 2005;17(3): 350-8. (Pubitemid 40188917)
4. Wolitski RJ, Kidder DP, Pals SL, Royal S, Aidala A, Stall R, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14(3):493-503.
5. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med. 2004;19(4):357-65.
6. Braitstein P, Montessori V, Chan K, Montaner J, Schechter M, O'Shaughnessy M, et al. Quality of life, depression and fatigue among persons co-infected with HIV and hepatitis C: Outcomes from a population-based cohort. AIDS Care. 2005;17(4):505-15. (Pubitemid 40663210)
7. Lieb S, Brooks RG, Hopkins RS, Thompson D, Crockett LK, Liberti T, et al. Predicting death from HIV/AIDS: A case-control study from Florida public HIV/AIDS clinics. J Acquir Immune Defic Syndr. 2002;30(3):351-8. (Pubitemid 34774084)
8. Schwarcz SK, Hsu LC, Vittinghoff E, Vu A, Bamberger JD, Katz MH. Impact of housing on the survival of persons with AIDS. BMC Public Health. 2009;9:220.
9. Walley AY, Cheng DM, Libman H, Nunes D, Horsburgh CR Jr, Saitz R, et al. Recent drug use, homelessness and increased shortterm mortality in HIV-infected persons with alcohol problems. AIDS. 2008;22(3):415.
10. Kidder D, Wolitski R, Royal S, Aidala A, Courtenay-Quirk C, Holtgrave D. Access to housing as a structural intervention for homeless and unstably housed people living with HIV: Rationale, methods, and implementation of the housing and health study. AIDS Behav. 2007;11:S149-61. (Pubitemid 350001035)
11. Kim TW, Kertesz SG, Horton NJ, Tibbetts N, Samet JH. Episodic homelessness and health care utilization in a prospective cohort of HIV-infected persons with alcohol problems. BMC Health Serv Res. 2006;6:19.
12. Smith MY, Rapkin BD, Winkel G, Springer C, Chhabra R, Feldman IS. Housing status and health care service utilization among low-income persons with HIV/AIDS. J Gen Intern Med. 2000;15(10):731-8.
13. Celentano DD, Vlahov D, Cohn S, Shadle VM, Obasanjo O, Moore RD. Self-reported antiretroviral therapy in injection drug users. J Am Med Assoc. 1998;280(6):544-6.
14. Bamberger JD, Unick J, Klein P, Fraser M, Chesney M, Katz MH. Helping the urban poor stay with antiretroviral HIV drug therapy. Am J Public Health. 2000;90(5):699-701. (Pubitemid 30246370)
15. Paterson DL, Swindells S, Mohr J. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30. (Pubitemid 30432540)
16. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450-4. (Pubitemid 28082255)
17. Porter K, Babiker A, Bhaskaran K, Darbyshire J, Pezzotti P, Walker AS. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Lancet. 2003; 362(9392):1267-74. (Pubitemid 37324254)
18. Royal SW, Kidder DP, Patrabansh S, Wolitski RJ, Holtgrave DR, Aidala A, et al. Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV. AIDS Care. 2009;21(4):448-55.
19. Bangsberg DR. Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43:939-41. (Pubitemid 44435526)
20. Cunningham CO, Sohler NL, Wong MD, Relf M, Cunningham WE, Drainoni ML, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDS. 2007;21(3):177-86. (Pubitemid 46608548)
21. Pulvirenti JJ, Glowacki R, Muppiddi U, Surapaneni N, Gail C, Kohl B, et al. Hospitalized HIV-infected patients in the HAART era: A view from the inner city. AIDS Patient Care STDS. 2003;17(11):565-73. (Pubitemid 37444833)
22. Roberts K, Volberding P. Adherence communication: A qualitative analysis of physician-patient dialogue. AIDS. 1999;13: 1771-8. (Pubitemid 30015726)
23. Shapiro MF, Morton SC, McCaffrey DE, Senterfitt JW, Fleishman JA, Perlman JF. Variations in the care of HIV-infected adults in the United States. Results from the HIV cost and services utilization study. J Am Med Assoc. 1999;281(24):2305-15. (Pubitemid 29289823)
24. Wong MD, Cunningham WE, Shapiro MF, et al. Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J Gen Intern Med. 2004;19: 366-74. (Pubitemid 38530508)
25. Bangsberg D, Tulsky JP, Hecht FM, Moss AR. Protease inhibitors in the homeless. J Am Med Assoc. 1997;278:63-5. (Pubitemid 27274519)
26. Berg KM, Demas PA, Howard AA, Schoenbaum EE, Gourevitch MN, Arnsten JH. Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Inter Med. 2004; 19(11):1111-7. (Pubitemid 39552581)
27. Carballo E, Cadarso-Suarez C, Carrera I, Fraga J, de la Fuente J, Ocampo A, et al. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Qual Life Res. 2004;13(3):587-99. (Pubitemid 38526534)
28. Johnson MO, Catz SL, Remien RH, Rotheram-Borus M, Morin SF, Charlebois E, et al. Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the healthy living project. AIDS Patient Care STDs. 2003;17(12):645-56. (Pubitemid 38031552)
29. Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti J. Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: From a predictive to a dynamic approach. Soc Sci Med. 2002;54(10):1481-96. (Pubitemid 34309013)
30. Wolitski RJ, Kidder DP, Fenton KA. HIV, homelessness, and public health: Critical issues and a call for increased action. AIDS Behav. 2007;11(6):167-71.
31. Parruti G, Manzoli L, Toro PM, D'amico G, Rotolo S, Graziani V, et al. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: Predictors and impact on virologic response and relapse. AIDS Patient Care STDs. 2006;20(1):48-56.
32. Boyer A, Indyk D. Shaping garments of care tools for maximizing adherence potential. Social Work Health Care. 2005; 42(3):151-66. (Pubitemid 44161878)
33. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAiliffe TL. Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-33.
34. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101-7. (Pubitemid 30482715)
35. Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13:1763-9. (Pubitemid 30015725)
36. Moss AR, Hahn JA, Perry S, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clin Infect Dis. 2004;39:1190-8. (Pubitemid 40169319)
37. Nilsson Schonnesson L, Diamond PM, Ross MW, Williams M, Bratt G. Baseline predictors of three types of antiretroviral therapy (ART) adherence: A 2-year follow-up. AIDS Care. 2006;18: 407-14.
38. Riley ED, Wu AW, Perry S, et al. Depression and drug use impact health status among marginally housed HIV-infected individuals. AIDS Patient Care STDS. 2003;17:401-6. (Pubitemid 37034255)
39. Starace F, Ammassari A, Trotta MP. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:S136-9. (Pubitemid 35453574)
40. Waldrop-Valverde D, Valverde E. Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users. AIDS Patient Care STDS. 2005;19:326-34. (Pubitemid 40770656)
41. Wood E, Kerr T, Palepu A, Zhang R, Strathdee SA, Tyndall MW, et al. Slower uptake of HIV antiretroviral therapy among Aboriginal injection drug users. J Infect. 2006;52(4):233-6.
42. Knowlton A, Arnsten J, Eldred L, Wilkinson J, Gourevitch M, Shade S. Individual, interpersonal, and structural correlates of effective HAART use among urban active injection drug users. J Acquir Immune Defic Syndr. 2006;41:486-92.
43. Tyndall MW, McNally M, Lai C, Zhang R, Wood E, Kerr T, et al. Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: Access, adherence and outcomes. Int J Drug Policy. 2007;18(4):281-7. (Pubitemid 47126277)
44. Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, Walton M, et al. Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: Implications for program replication. Clin Infect Dis. 2004;38(Suppl 5):S376-87. (Pubitemid 38738534)
45. Conway B, Prasad J, Reynolds R, Farley J, Jones M, Jutha S, et al. Directly observed therapy for the management of HIVinfected patients in a methadone program. Clin Infect Dis. 2004;38(Suppl 5):S402-8. (Pubitemid 38738538)
46. Bangsberg DR, Mundy LM, Tulsky JP. Expanding directly observed therapy: Tuberculosis to human immunodeficiency virus. Am J Med. 2001;110(8):664-6. (Pubitemid 32510697)
47. McCance-Katz EF, Gourevitch MN, Arnsten J, Sarlo J, Rainey P, Jatlow P. Modified directly observed therapy (MDOT) for injection drug users with HIV disease. Am J Addict. 2002; 11(4):271-8. (Pubitemid 35332504)
48. Maru DS, Bruce RD, Walton M, Mezger JA, Springer SA, Shield D, et al. Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy. AIDS Behav. 2008;12(2):284-93.
49. Mitchell CG, Freels S, Creticos CM, Oltean A, Douglas R. Preliminary findings of an intervention integrating modified directly observed therapy and risk reduction counseling. AIDS Care. 2007;19(4):561-4. (Pubitemid 46598745)
50. Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, et al. A randomized clinical trial of communitybased directly observed therapy as an adherence intervention for HAART among substance users. AIDS. 2007;21(11):1473-7. (Pubitemid 46988008)
51. Altice FL, Maru DS, Bruce RD, Springer SA, Friedland GH. Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: A prospective, randomized, controlled trial. Clin Infect Dis. 2007; 45(6):770-8. (Pubitemid 47378892)
52. Hay H. TheMATProgram-Maximally Assisted Therapy: Helping HIV positive people with antiretroviral medications. Living Posit Mag. 2000;(4):8-9. http://www.positivelivingbc.org/files/bcpwa/ articles/issue4.pdf.
53. Webster K. Welcome MAT: Antiretroviral adherence program is a success story in the Downtown Eastside. Living Posit Mag. 2008;(55):29. http://www.positivelivingbc.org/files/bcpwa/articles/ issue55.pdf.
54. Thompson MA, Aberg JA, Cahn P, Montaner JSG, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA. 2010;304(3):321.
55. BC Centre for Excellence in HIV/AIDS. Therapeutic guidelines: Antiretroviral treatment of adult HIV infection. 2009; Available at: Http://www.cfenet.ubc.ca/sites/default/files/uploads/docs/Adult-Therapeutic- Guidelines.pdf. Accessed September 2010.
56. Racey CS, Zhang W, Brandson EK, Fernandes KA, Tzemis D, Harrigan PR, et al. HIV antiviral drug resistance: Patient comprehension. AIDS Care. 2010;22(7):816-26.
57. Wood E, Montaner J, Yip B. Adherence and plasma HIV RNA responses to highly active anti-retroviral therapy among HIV-1 infected injection drug users. Can Med Assoc J. 2003;169: 656-61. (Pubitemid 37266973)
58. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol. 1997;50(1):105-16. (Pubitemid 27089212)
59. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: Evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med. 1994;10(2):77-84. (Pubitemid 24144960)
60. Kendall A, Olson CM, Frongillo EA Jr. Validation of the Radimer/ Cornell measures of hunger and food insecurity. J Nutr. 1995;125(11):2793-801.
61. Radimer KL, Olson CM, Campbell CC. Development of indicators to assess hunger. J Nutr. 1990;120(11-Suppl):1544-8.
62. Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA. 1984;252(14):1905-7.
63. SAS Institute. SAS/STAT user's guide: Version 9.1.3, Version 9. Cary: SAS Institute; 2008.
64. Joy R, Druyts EF, Brandson EK, Lima VD, Rustad CA, Zhang W, et al. Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting. J Acquir Immune Defic Syndr. 2008;47(4):500-5. (Pubitemid 351366966)
65. Strathdee SA, Palepu A, Cornelisse PG, Yip B, O'Shaughnessy MV, Montaner JS, et al. Barriers to use of free antiretroviral therapy in injection drug users. JAMA. 1998;280(6):547-9. (Pubitemid 28377675)
66. Conover CJ, Whetten-Goldstein K. The impact of ancillary services on primary care use and outcomes for HIV/AIDS patients with public insurance coverage. AIDS Care. 2002;14(Suppl 1): S59-71.
67. Bica I, Tang AM, Skinner S, Spiegelman D, Knox T, Gorbach S, et al. Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy. J Altern Complement Med. 2003; 9(1):65-76. (Pubitemid 36292745)
68. Dasinger LK, Speiglman R. Homelessness prevention: The effect of a shallow rent subsidy program on housing outcomes among people with HIV or AIDS. AIDS Behav. 2007;11(6):128-39.
69. Leaver CA, Bargh G, Dunn JR, Hwang SW. The effects of housing status on health-related outcomes in people living with HIV: A systematic review of the literature. AIDS Behav. 2007; 11(6):85-100.
70. Cisneros H. Policy perspective on housing and HIV/AIDS. AIDS Behav. 2007;11(6):7-8.
71. Shubert V, Bernstine N. Moving from fact to policy: Housing is HIV prevention and health care. AIDS Behav. 2007;11(6):172-81.
72. City of Vancouver. Supportive Housing in Vancouver. 2010. Available at: Http://vancouver.ca/commsvcs/housing/supportive housingstrategy/. Accessed 20 Dec 2010.
73. Public Health Agency of Canada. Federal initiative to address HIV/AIDS in Canada 2007. 2010. Available at: Http://www. phac-aspc.gc.ca/aids-sida/fi-if/ index-eng.php. Accessed 20 Dec 2010.
74. Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, et al. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention. Clin Infect Dis. 2006;42(11):1619-27.